ESC Congress 2026 Abstract·Oct 26SGLT2 inhibitor empagliflozin remodels pericardial fat–derived lipids-initiated ventricular ion-channel function to reduce arrhythmogenic electrical remodeling in diabetic heartsExperiments in miceSGLT2 inhibitorsPaper